BioCentury
ARTICLE | Company News

FDA approves Cangene's botulism antitoxin

March 26, 2013 12:43 AM UTC

FDA approved a BLA from Cangene Corp. (TSX:CNJ) for botulism antitoxin heptavalent (BAT) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin....